Literature DB >> 32205960

Male Breast Cancer: Current Trends-a Tertiary Care Centre Experience.

Tanay Shah1, Niket Shah1, D G Vijay1, Bhavesh Patel1, Samir Patel1.   

Abstract

Male breast cancer is a rare tumour in all parts of the world. About 1% of all breast cancers occur in men. Occurrence of male breast cancer peaks at age 71 years. Familial cases usually have BRCA2 rather than BRCA1 mutations. Presentation is usually a lump or nipple inversion, but is often late, with more than 40% of individuals having stage III or IV disease. We retrospectively reviewed 25 male patients with breast cancer who came to the HCG Cancer Centre, Ahmedabad between 2014 and 2018, and their demographic details, tumor profile, and radiological, histopathological as well as luminal profile findings were studied. The average age at presentation and detection of male breast cancer was 61.08 years. Incidence of male ca. breast over these 4 years was 4.75/year which had a significant increase compared with our own data in the last 8 years (3/year). Male to female ratio for ca. breast was 1:61. One out of 25 (4%) patients had gynaecomastia. The most common histology was invasive ductal carcinoma-not otherwise specified with none of the patients having lobular carcinoma. Majority of patients were ER/PR positive and HER-2 negative. Male breast cancer is having a rising incidence, which in our study is 1.56%. Males have relatively older age at presentation and stage-by-stage treatment remains the same. Males are more likely to be having prognostically favourable luminal subtypes. Male breast cancer in Indian population is currently experiencing an increasing trend. Improved awareness amongst patients and high index of suspicion by the clinicians along with accurate diagnostic techniques help detect the disease at an earlier stage culminating into prolonged overall and disease-free survival. © Indian Association of Surgical Oncology 2019.

Entities:  

Keywords:  Breast; Male breast cancer; Tumour

Year:  2019        PMID: 32205960      PMCID: PMC7064676          DOI: 10.1007/s13193-019-01021-5

Source DB:  PubMed          Journal:  Indian J Surg Oncol        ISSN: 0975-7651


  12 in total

1.  Mutations in BRCA2 and PALB2 in male breast cancer cases from the United States.

Authors:  Yuan Chun Ding; Linda Steele; Chih-Jen Kuan; Scott Greilac; Susan L Neuhausen
Journal:  Breast Cancer Res Treat       Date:  2010-10-07       Impact factor: 4.872

2.  PALB2 mutations in male breast cancer: a population-based study in Central Italy.

Authors:  Valentina Silvestri; Piera Rizzolo; Ines Zanna; Mario Falchetti; Giovanna Masala; Simonetta Bianchi; Laura Papi; Giuseppe Giannini; Domenico Palli; Laura Ottini
Journal:  Breast Cancer Res Treat       Date:  2010-02-24       Impact factor: 4.872

3.  Male breast cancer in the hereditary nonpolyposis colorectal cancer syndrome.

Authors:  J Boyd; E Rhei; M G Federici; P I Borgen; P Watson; B Franklin; B Karr; J Lynch; S J Lemon; H T Lynch
Journal:  Breast Cancer Res Treat       Date:  1999-01       Impact factor: 4.872

4.  Male breast cancer: a population-based comparison with female breast cancer.

Authors:  William F Anderson; Ismail Jatoi; Julia Tse; Philip S Rosenberg
Journal:  J Clin Oncol       Date:  2009-12-07       Impact factor: 44.544

5.  Male breast cancer: an 11 year review of 66 patients.

Authors:  S A McLachlan; C Erlichman; F F Liu; N Miller; M Pintilie
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

6.  Incidence and outcome of male breast cancer: an international population-based study.

Authors:  Hui Miao; Helena M Verkooijen; Kee-Seng Chia; Christine Bouchardy; Eero Pukkala; Siri Larønningen; Lene Mellemkjær; Kamila Czene; Mikael Hartman
Journal:  J Clin Oncol       Date:  2011-10-03       Impact factor: 44.544

7.  Breast cancer in males: a PGIMER experience.

Authors:  Bhavana Rai; Sushmita Ghoshal; Suresh C Sharma
Journal:  J Cancer Res Ther       Date:  2005 Jan-Mar       Impact factor: 1.805

Review 8.  Male breast cancer.

Authors:  Ian S Fentiman; Alain Fourquet; Gabriel N Hortobagyi
Journal:  Lancet       Date:  2006-02-18       Impact factor: 79.321

9.  Male breast carcinoma: an evaluation of prognostic factors contributing to a poorer outcome.

Authors:  M G Joshi; A K Lee; M Loda; M G Camus; C Pedersen; G J Heatley; K S Hughes
Journal:  Cancer       Date:  1996-02-01       Impact factor: 6.860

10.  Clinicopathological study of male breast carcinoma: 24 years of experience.

Authors:  Parveen Shah; Irfan Robbani; Omar Shah
Journal:  Ann Saudi Med       Date:  2009 Jul-Aug       Impact factor: 1.526

View more
  1 in total

1.  Multi-gene panel testing increases germline predisposing mutations' detection in a cohort of breast/ovarian cancer patients from Southern Italy.

Authors:  Marcella Nunziato; Federica Di Maggio; Matilde Pensabene; Maria Valeria Esposito; Flavio Starnone; Carmine De Angelis; Alessandra Calabrese; Massimiliano D'Aiuto; Gerardo Botti; Sabino De Placido; Valeria D'Argenio; Francesco Salvatore
Journal:  Front Med (Lausanne)       Date:  2022-08-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.